TipRanks
Go Ultimate55% OFF

Lennie Ryer Insider Profile

4 Followers

Lennie Ryer, Director at PharmAla Biotech Holdings, Inc., holds 36.00K shares in PharmAla Biotech Holdings, Inc. (Ticker: TSE:MDMA), holds 116.14K shares in SQI Diagnostics (Ticker: TSE:SQD.H), holds 591.08K shares in Cannara Biotech (Ticker: LOVFF). Most recently, Lennie Ryer Bought ― shares of PharmAla Biotech Holdings, Inc. on May 22, 2026 for an estimated value of C$5.40K.

Lennie Ryer's Trading History

MDMA
PharmAla Biotech Holdings, Inc.
May 22, 2026DirectorInformative Buy5.40KC$6.12K
SQD.H
SQI Diagnostics
Oct 28, 2015―Informative Buy12.25KC$1.74K
LOVFF
Cannara Biotech
―Chief Financial Officer―$851.15K

You May Also Like

Lennie Ryer insider profile FAQ

What is the percentage of profitable transactions made by Lennie Ryer?
The percentage of profitable transactions made by Lennie Ryer is 25%.
What is the average return per transaction made by Lennie Ryer?
The average return per transaction made by Lennie Ryer is -29.00%.
What stocks does Lennie Ryer hold?
Lennie Ryer holds: TSE:MDMA, TSE:SQD.H, LOVFF stocks.
What was Lennie Ryer’s latest transaction?
Lennie Ryer’s latest transaction was an Informative Buy of C$5.40K.
What was Lennie Ryer's most profitable transaction?
Lennie Ryer’s most profitable transaction was an Informative Buy of TSE:MDMA stock on May 22, 2026. The return on the trade was 17.20%.
What is Lennie Ryer's role in PharmAla Biotech Holdings, Inc.?
Lennie Ryer's role in PharmAla Biotech Holdings, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.